![Oragenics, Inc. [OGEN] Price Analysis: NYSE:OGEN Bull Target $2.25 or Higher](https://globalresearchsyndicate.com/wp-content/uploads/2020/03/uxejdx4sqde.jpg)
The share price of Oragenics, Inc. [NYSE: OGEN] inclined by $0.58, presently trading at $0.66. The company’s shares saw 87.89% gains compared to the lowest price in the period of the last 52 weeks, set at $0.35 recorded on 02/27/20. The last few days have been benevolent to the share price as OGEN jumped by +6.15% during the last week, even though the stock is still down by -3.39% compared to 0.04 of all time high it touched on 02/28/20. However, the stock had a strong performance during the past 3 months, roughly gaining 34.65%, while additionally dropping -34.44% during the last 12 months. Oragenics, Inc. is said to have a 12-month price target set at $2.25. That means that the stock has a strong potential to acquire 1.59% increase from the current trading price.
Oragenics, Inc. [NYSE:OGEN]: Analyst Rating and Earnings
This is compared to its latest closing price of $0.58.
Keep your eyes peeled for the soon-to-be-published financial results of this company, which are expected to be made public on 02/28/2020.
Fundamental Analysis of Oragenics, Inc. [OGEN]
Turning to investigate this organization’s capital structure, Oragenics, Inc. [OGEN] has generated a Total Debt to Total Equity ratio of 0.59. Similarly, its Total Debt to Total Capital is 0.59, while its Total Debt to Total Assets stands at 0.56.
What about valuation? This company’s Enterprise Value to EBITDA is -0.04. Total Debt to Enterprise Value stands at -0.04. Oragenics, Inc. [OGEN] has a Price to Book Ratio of 1.71.
This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 18.79 and its Current Ratio is 18.79. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Oragenics, Inc. [OGEN] has 46.13M shares outstanding, amounting to a total market cap of $26.94M. Its stock price has been found in the range of 0.35 to 0.99. At its current price, it has moved down by -33.58% from its 52-week high, and it has moved up 87.89% from its 52-week low.
This stock’s Beta value is currently 1.54, which indicates that it is 12.91% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 64.59. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Oragenics, Inc. [OGEN] a Reliable Buy?
Shares of Oragenics, Inc. [OGEN], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.
